Submitted by admin on September 20, 2022 - 10:55am
Abbott’s latest Amulet-Watchman data show more mixed results for the heart devices
Merck finally gets FDA nod to relaunch HIV trials, but drops preventive therapy plans
Celsion rebrands to Imunon
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
*please scroll down for all the latest news*
